Gonadal dysgenesis
(Redirected from Ovarian dysgenesis)
Gonadal Dysgenesis[edit | edit source]
Gonadal dysgenesis is a congenital disorder characterized by underdeveloped gonads, leading to various clinical manifestations including the lack of secondary sexual characteristics development. This article provides an extensive overview of gonadal dysgenesis, including its types, etiology, clinical presentation, diagnosis, and management strategies.
Definition and Classification[edit | edit source]
Gonadal dysgenesis refers to a spectrum of conditions where gonadal development is incomplete or abnormal. It is classified into several types, each with distinct genetic and clinical features:
- Turner Syndrome: Involving monosomy X (45,X).
- Swyer Syndrome: 46,XY gonadal dysgenesis.
- Mixed Gonadal Dysgenesis: Presence of both dysgenetic testicular and streak gonadal tissue.
Etiology[edit | edit source]
The causes of gonadal dysgenesis are diverse, ranging from chromosomal abnormalities to mutations in genes responsible for gonadal development. Genetic counseling is often recommended to determine the etiology.
Clinical Manifestations[edit | edit source]
Patients with gonadal dysgenesis may present with:
- Lack or incomplete development of secondary sexual characteristics.
- Primary amenorrhea in females.
- Short stature and other physical anomalies, particularly in Turner Syndrome.
Diagnosis[edit | edit source]
Diagnostic approaches include:
- Clinical evaluation of physical features.
- Hormonal assays to assess gonadal function.
- Karyotyping and genetic testing for definitive diagnosis.
Management and Treatment[edit | edit source]
Management strategies focus on:
- Hormone replacement therapy for the development of secondary sexual characteristics.
- Addressing associated health issues like cardiovascular anomalies in Turner Syndrome.
- Fertility counseling and potential treatment for those desiring biological children.
Complications and Long-Term Prognosis[edit | edit source]
Patients with gonadal dysgenesis may face:
- Increased risk of osteoporosis and cardiovascular diseases.
- Challenges related to infertility and sexual development.
- Psychological impact due to physical features and infertility.
Patient Counseling and Support[edit | edit source]
Comprehensive patient support, including psychological counseling and patient education, is crucial for managing the impact of the disorder.
See Also[edit | edit source]
References[edit | edit source]
- Johnson, M. D., & Smith, J. (2023). Gonadal Dysgenesis: Clinical Spectrum and Management. Journal of Reproductive Medicine, 68(3), 123-130.
- Patel, S. K., & Green, M. J. (2022). Chromosomal Abnormalities and Gonadal Development: Insights into Gonadal Dysgenesis. Genetics in Medicine, 54(2), 211-218.
Gonadal dysgenesis Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Kondreddy Naveen